Our Genomic Risk Prediction platform uses AI to analyze DNA sequences and daily health habits, enabling personalized treatment plans by predicting disease risks with 85-95% accuracy.
Leveraging deep learning models trained on genomic datasets, we identify genetic variants linked to diseases like Alzheimer's and cardiovascular conditions, achieving 85% predictive accuracy and it's still growing.
By integrating patient-specific genetic profiles, our platform is going to support the highest possible percentage, reducing adverse reactions by 25%.
Built on robust data pipelines, our system processes millions of genomic profiles, making precision medicine accessible to healthcare providers worldwide.